Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 124 clinical trials
Multicomponent Integrated Intervention on Metabolic Control and Quality of Life in Type 2 Diabetes: DIABEMPIC Program

Type 2 diabetes is one of the leading causes of morbidity and mortality rate in Mexico. Although important advances in treatment strategies have been developed in type 2 diabetes mellitus, large gaps exist in achieving quality of care.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island.

The management of diabetes and its complications in Reunion island is one of the priority areas of health. Indeed, the impact of diabetes on the health of the Reunion island population is major: the prevalence of diabetes treated in Reunion island is the highest in France (10% of the population), …

myocardial infarction
hyperglycemia
glucose intolerance
diabetes
prediabetic state
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
body mass index
tirzepatide
dulaglutide
  • 0 views
  • 19 Feb, 2024
  • 651 locations
Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

With this background, we aim to test the hypothesis that the use of simple fibrosis scores as part of a diabetes complications screening program followed by electronic reminder messages is more effective than usual care in prompting physicians to correctly identify patients with suspected NAFLD and advanced liver fibrosis for …

diabetes
type 2 diabetes mellitus
nash
liver cancer
diabetic complication
  • 0 views
  • 19 Feb, 2024
  • 1 location
Evaluation of Diabetes and WELLbeing Programme

This study evaluates the impact of 'DWELL' - a 12-week psycho-social education programme designed to help people with type 2 diabetes to better self-manage their condition. Up to 800 patients will participate in the programme, while a non-intervention group will receive routine care for their diabetes

  • 0 views
  • 19 Feb, 2024
  • 5 locations
Asian Diabetes Outcomes Prevention Trial

The aim of this study is to identify patients with DM at high risk of CVD using elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125pg/mL), and (2) intensify therapy using renin-angiotensin system (RAS) antagonists, beta-blockers and sodium glucose co-transporter-2 inhibitors (SGLT2i) for primary prevention of cardiovascular events in this high-risk …

stenosis
beta-blocker
angiotensin
type 2 diabetes mellitus
type 1 diabetes mellitus
  • 0 views
  • 19 Feb, 2024
  • 1 location
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

Comparison of Angiography-derived Fractional FLow Reserve And IntraVascular Ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with CoRonary Artery Disease

stenosis
angiography
intravascular ultrasound
arterial disease
heart disease
  • 2 views
  • 19 Feb, 2024
  • 15 locations
Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory …

plasma glucose
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

The patients with type 2 diabetes mellitus (T2DM) is expected to rise to 439 million in 2030, accounting for 7.7% the population in the world. There are nearly 10 million T2DM patients with mild cognitive impairment (MCI) among people over 65 years old , accounting for about 8% of the …

diabetes
demented
type 2 diabetes mellitus
mild cognitive impairment
rehabilitation therapy
  • 0 views
  • 19 Feb, 2024
  • 1 location
The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study in patients with type 2 diabetes mellitus (T2DM).

monitors blood glucose
fasting blood glucose
antidiabetic agent
fasting
blood glucose self-monitoring
  • 0 views
  • 19 Feb, 2024
  • 1 location